Related Experiment Videos

The combination of HLA-DR1 and HLA-DR53 protects against MS

M Luomala1, I Elovaara, M Ukkonen

  • 1Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, Finland. mari.luomala@csc.fi

Neurology
|February 15, 2001
PubMed

Insights

Certain human leukocyte antigen (HLA) alleles influence multiple sclerosis (MS) risk. DRB1*15 significantly elevates MS risk, while DR1 and DR53 alleles offer protection, particularly in combination.

Area of Science:

  • Immunogenetics
  • Neuroimmunology
  • Human Genetics

Background:

  • The human leukocyte antigen (HLA) complex plays a crucial role in immune regulation.
  • Specific HLA alleles are associated with an increased or decreased risk of developing autoimmune diseases like multiple sclerosis (MS).
  • Understanding the genetic basis of MS susceptibility is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate the association between HLA-DRB1/3/4/5 alleles and the risk of multiple sclerosis (MS).
  • To identify specific alleles or combinations of alleles that confer protection or susceptibility to MS.

Main Methods:

  • Genotyping of HLA-DRB1/3/4/5 loci in 97 patients with MS and 100 healthy controls.
  • Statistical analysis using odds ratios (OR) and p-values to determine the significance of allele associations.

Main Results:

  • The DRB1*15 allele was significantly associated with an increased risk of MS (OR = 4.2, p < 0.0001).
  • The DR1 allele demonstrated a decreased risk of MS (OR = 0.30, p(c) = 0.005).
  • A combination of DR1 and DR53 alleles showed the strongest protective effect against MS (OR = 0.05, p < 0.0001).

Conclusions:

  • HLA-DRB1*15 is a significant risk factor for MS.
  • DR1 and DR53 alleles, especially in combination, appear to have a protective effect against MS.
  • DR53 may be a key genetic factor, working with DR1, to confer resistance to MS.

Related Concept Videos